Pharma: Cephalon Inks Australian Investment
October 25, 2010 (FinancialWire) ( http://www.financialwire.net/ ) — Cephalon, Inc. (NASDAQ: CEPH) said it has signed a convertible note subscription agreement with ChemGenex Pharmaceuticals Ltd. (ASX: CXS), an Australian-based oncology …